The company’s cutting-edge platform technology – RightSize™ Particle manufacturing – uses supercritical fluid as an antisolvent for controlled precipitation of an active pharmaceutical ingredient/drug substance. The technology provides a superior process to traditional methods and delivers better quality particles.

Importantly, the technology can also be effectively scaled up to drug manufacturing volumes.

By producing consistent powder particles, with full control over size, shape and morphology, XSpray helps pharmaceutical companies to simplify drug formulation and to develop drugs with enhanced delivery options.

XSpray provides development services, particle manufacturing for lab use or clinical trials and solid state characterization services, as well as licensing of its proprietary technology.

The company has its headquarters and development laboratories in Stockholm, Sweden. GMP production takes place at a state-of-the-art manufacturing facility in Malmö, Sweden.